Imperial College London
Alternate

Dr Nik Ding

Faculty of Medicine, Department of Surgery & Cancer

Honorary Clinical Lecturer
 
 
 
//

Contact

 

n.ding

 
 
//

Location

 

Northwick ParkNorthwick Park and St Marks Site

//

Summary

 

Publications

Citation

BibTex format

@article{Hui:2020:10.1002/14651858.CD013611,
author = {Hui, S and Krishna, A and Ding, NS and Boyapati, RK},
doi = {10.1002/14651858.CD013611},
journal = {Cochrane Database of Systematic Reviews},
title = {Vedolizumab for induction and maintenance of remission in Crohn’s disease},
url = {http://dx.doi.org/10.1002/14651858.CD013611},
volume = {2020},
year = {2020}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. The primary objective of this systematic review of the literature is to assess the efficacy and safety of vedolizumab in the induction and maintenance of remission in Crohn's disease.
AU  - Hui,S
AU  - Krishna,A
AU  - Ding,NS
AU  - Boyapati,RK
DO  - 10.1002/14651858.CD013611
PY  - 2020///
TI  - Vedolizumab for induction and maintenance of remission in Crohn’s disease
T2  - Cochrane Database of Systematic Reviews
UR  - http://dx.doi.org/10.1002/14651858.CD013611
VL  - 2020
ER  -
Download